血管新生抑制剤開発
スポンサーリンク
概要
- 論文の詳細を見る
- 公益社団法人日本薬学会の論文
- 1995-10-01
著者
関連論文
- POSSIBLE FUNCTIONAL GROUPS RESPONSIBLE FOR INHIBITION OF IN VIVO ANGIOGENESIS BY HERBIMYCIN A
- マウス移植腫瘍細胞M5076が誘導する血管新生に対する微生物代謝産物リゾキシンの抑制作用
- INHIBITION OF ANGIOGENESIS BY BLEOMYCIN AND ITS COPPER COMPLEX
- 血管新生抑制薬
- 血管新生抑制剤開発
- DEPUDECIN, A MICROBIAL METABOLITE CONTAINING TWO EPOXIDE GROUPS, EXHIBITS ANTI-ANGIOGENIC ACTIVITY IN VIVO
- THREE ISOFORMS OF PLATELET-DERIVED GROWTH FACTORS ALL HAVE THE CAPABILITY TO INDUCE ANGIOGENESIS IN VIVO
- 腫瘍血管新生 (血管内皮細胞--研究における最近の動向) -- (血管新生と内皮細胞)
- Immunological Properties of Type IV Collagen from Mouse Kidney
- Purification and Characterization of Type IV Collagen from Mouse Kidney
- Purification of Cathepsin D from Guinea Pig Peritoneal Macrophages